India Private Hospital Sector Report 2023

2023-05-26
AHA会议
DUBLIN, May 26, 2023 /PRNewswire/ -- The "Private Hospital Sector in India 2023" report has been added to
ResearchAndMarkets.com's offering.
The private hospital sector in India was valued at INR 11,606.50 Bn in FY 2022. It is expected to reach INR 26,825.45 Bn by FY 2027, expanding at a compound annual growth rate (CAGR) of ~18.60% during the FY 2023 - FY 2027 forecast period.
In India, private hospitals are essential to the provision of healthcare services. Around 70% of people living in rural areas and about 80% of people living in cities largely rely on private hospitals as their primary source of healthcare. The healthcare system would be thoroughly strengthened by the Ayushman Bharat Yojana, from primary to tertiary care.
Segment insights:
The self-pay segment dominated the market in FY 2022, accounting for 40.66% of total revenue. The second-largest segment was government payer, followed by corporate insurer.
The self-pay segment is expected to decline in market share, falling from 40.66% in FY 2022 to 35.21% in FY 2027. The expansion of insurance coverage by both government and corporate insurers is expected to reduce the self-pay market segment's share.
Market drivers:
In comparison to government hospitals, private hospitals are better equipped to handle severe illnesses, have a better healthcare workforce, provide better treatment, and so on.
Government hospital hygiene issues, a lack of proper treatment/facilities, better insurance to cover costs, personalised services, disposable income, and other factors have led to an increase in demand for private hospitals.
Choosing private hospitals, home healthcare, and preventive care can reduce the likelihood of contracting chronic and noncommunicable diseases.
Market challenges:
Many people believe that private hospitals are prohibitively expensive, and that even minor treatments are overpriced. Besides that, changes to the Patient Protection and Affordable Care Act (PPACA) have resulted in significant reductions in reimbursements for some healthcare providers, including private hospitals.
Furthermore, lack of trained medical personnel makes it difficult for private hospitals to operate efficiently, jeopardizing their profitability and prominence.
Key Topics Covered:
Chapter 1: Executive summary
Chapter 2: Socio-economic indicators
Chapter 3: Introduction
3.1. Market definition and structure
Chapter 4: Market overview
4.1. Private hospital sector in India - An overview
4.1.1. Market size and growth forecast based on value (FY 2021 - FY 2027e)
Chapter 5: Market segmentation
5.1. India private hospital market based on payers (FY 2022 and FY 2027e)
5.1.1. Self-pay market in India - Market size and growth forecast (FY 2021 - FY 2027e)
5.1.2. Government payer market in India - Market size and growth forecast (FY 2021 - FY 2027e)
5.1.3. Corporate insurer market in India - Market size and growth forecast (FY 2021 - FY 2027e)
Chapter 6: Impact of COVID-19
6.1. Impact of COVID-19
Chapter 7: Market influencers
7.1. Market drivers
7.2. Market challenges
Chapter 8: Competitive landscape
Chapter 9: Recent developments
For more information about this report visit https://www.researchandmarkets.com/r/haukdx
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。